Specific cancer types like BRCA, LGG, and HNSC show frequent mutations in genes like TP53, PIK3CA, and CDKN2A, providing insights that may guide therapeutic strategies (Supplementary Figure 5A). The gene discussed is CDKN2A; the disease is cancer.